Trends in Government‐Subsidised Menopausal Hormone Therapy Dispensing in Australia Between 2014 and 2023
Open Access
- 24 April 2026
- journal article
- Published by Wiley in Australian and New Zealand Journal of Obstetrics and Gynaecology
- Vol. 66 (2) , e70135
Abstract
Menopausal hormone therapy (MHT) is a mainstay treatment for menopausal symptoms. While international studies report rising MHT use, trends in Australia remain unclear. Using a 10% random sample of Pharmaceutical Benefits Scheme (PBS) data from 2014 to 2023, we analysed the prevalence of MHT dispensing among women aged 45–64. Overall prevalence of MHT dispensing remained stable (relative annual change: 0.42%, 95% CI −0.50 to 1.35). Use of transdermal and intrauterine device (IUD) MHT increased (5.89%, 95% CI 3.88–7.91 and 10.22%, 95% CI 9.48–10.95, respectively), and vaginal MHT decreased (−1.47%, 95% CI −2.30 to −0.63), while oral MHT appeared stable (0.66%, 95% CI −0.04 to 1.36). This study offers a clearer understanding of how MHT use in Australia has changed over the last decade.Keywords
This publication has 16 references indexed in Scilit:
- Effects of transdermal versus oral hormone replacement therapy in postmenopause: a systematic reviewArchives of Gynecology and Obstetrics, 2022
- Australian women’s understanding of menopause and its consequences: a qualitative studyClimacteric, 2020
- Menopause: diagnosis and management2019
- The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic reviewHuman Reproduction Update, 2018
- Perimenopausal contraception: A practice-based approach.2017
- 2016 IMS Recommendations on women’s midlife health and menopause hormone therapyClimacteric, 2016
- The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchersBMC Research Notes, 2015
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsJAMA, 2013
- Evolution of postmenopausal hormone therapy between 2002 and 2009Menopause, 2012
- Changes in utilisation of hormone replacement therapy in Australia following publication of the findings of the Women's Health InitiativePharmacoepidemiology and Drug Safety, 2008